Estimating uncertainties of HPV16/18 vaccination – a dynamic modelling approach
Abstract
Whether HPV16/18 vaccination should be introduced into the Norwegian childhood vaccination programme is currently being discussed. The National Council on Quality and Prioritisation in Health Care discussed the matter in December 2007, and asked the Norwegian Knowledge Centre for the Health Services using a dynamic health economic model to quantify how several unresolved issues regarding long-term efficacy may affect the future burden of cervical cancer and health economics of HPV 16/18 vaccination. Estimating uncertainties of HPV16/18 vaccination – a dynamic modelling approach